Bo Kruse, EVP, CFO, Secretary & Treasurer at Y-mAbs Therapeutics, Inc. (YMAB), sold 200,000 shares at $36.03 ($7.3M) on 2020-05-14, disclosed to the SEC on 2020-05-15.
Open-market sale of $7.3M YMAB by EVP, CFO, Secretary & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.86 | 14,724 | $557K | 7.6% |
| 2 | $37.86 | 14,724 | $557K | 7.6% |
| 3 | $37.88 | 19,230 | $728K | 9.9% |
| 4 | $37.88 | 19,230 | $728K | 9.9% |
| 5 | $36.03 | 28,199 | $1.0M | 13.9% |
| 6 | $36.03 | 28,199 |
| $1.0M |
| 13.9% |
| 7 | $36.03 | 37,847 | $1.4M | 18.6% |
| 8 | $36.03 | 37,847 | $1.4M | 18.6% |
| Total | $36.66 avg | 200,000 | $7.3M | 100% |
| Filing → |
| YMAB | SELL | 2022-02-07 | $32K | — | Filing → |
| YMAB | SELL | 2022-01-25 | $39K | — | Filing → |
| YMAB | SELL | 2022-01-05 | $68K | — | Filing → |